Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

14 páginas

Autores:
Restrepo, Marcos I.
Babu, Bettina L.
Reyes, Luis F.
Chalmers, James D.
Soni, Nilam J.
Sibila, Oriol
Faverio, Paola
Cilloniz, Catia
Rodriguez Cintron, William
Aliberti, Stefano
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
eng
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/41419
Acceso en línea:
https://erj.ersjournals.com/content/52/2/1701190.long
https://erj.ersjournals.com/content/erj/52/2/1701190.full.pdf
https://pubmed.ncbi.nlm.nih.gov/29976651/
http://hdl.handle.net/10818/41419
Palabra clave:
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id REPOUSABA2_21dbe9cdd5d3034c063429265b358e70
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/41419
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
spelling Restrepo, Marcos I.Babu, Bettina L.Reyes, Luis F.Chalmers, James D.Soni, Nilam J.Sibila, OriolFaverio, PaolaCilloniz, CatiaRodriguez Cintron, WilliamAliberti, Stefano6/2/2020 8:432020-06-02T13:43:29Z2018-06-06Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 2018; 52: 1701190 [https://doi.org/10.1183/13993003.01190-2017].0903-1936https://erj.ersjournals.com/content/52/2/1701190.longhttps://erj.ersjournals.com/content/erj/52/2/1701190.full.pdfhttps://pubmed.ncbi.nlm.nih.gov/29976651/http://hdl.handle.net/10818/4141910.1183 / 13993003.01190-201714 páginasPseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the antibiotics used most frequently in patients with community-acquired pneumonia (CAP). Data about the global burden and risk factors associated with P. aeruginosa-CAP are limited. We assessed the multinational burden and specific risk factors associated with P. aeruginosa-CAP. We enrolled 3193 patients in 54 countries with confirmed diagnosis of CAP who underwent microbiological testing at admission. Prevalence was calculated according to the identification of P. aeruginosa. Logistic regression analysis was used to identify risk factors for antibiotic-susceptible and antibiotic-resistant P. aeruginosa-CAP. The prevalence of P. aeruginosa and antibiotic-resistant P. aeruginosa-CAP was 4.2% and 2.0%, respectively. The rate of P. aeruginosa CAP in patients with prior infection/colonisation due to P. aeruginosa and at least one of the three independently associated chronic lung diseases (i.e. tracheostomy, bronchiectasis and/or very severe chronic obstructive pulmonary disease) was 67%. In contrast, the rate of P. aeruginosa-CAP was 2% in patients without prior P. aeruginosa infection/colonisation and none of the selected chronic lung diseases. The multinational prevalence of P. aeruginosa-CAP is low. The risk factors identified in this study may guide healthcare professionals in deciding empirical antibiotic coverage for CAP patientsapplication/pdfengEuropean Respiratory JournalEur Respir J 2018; 52: 1701190Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Universidad de La SabanaIntellectum Repositorio Universidad de La SabanaBurden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patientsCarga y factores de riesgo para la neumonía adquirida en la comunidad de Pseudomonas aeruginosa : un estudio multinacional de prevalencia puntual de pacientes hospitalizadosarticlepublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://intellectum.unisabana.edu.co/bitstream/10818/41419/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/41419/3/license.txtf52a2cfd4df262e08e9b300d62c85cabMD5310818/41419oai:intellectum.unisabana.edu.co:10818/414192022-05-10 05:20:08.76Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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
dc.title.es_CO.fl_str_mv Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
dc.title.alternative.es_CO.fl_str_mv Carga y factores de riesgo para la neumonía adquirida en la comunidad de Pseudomonas aeruginosa : un estudio multinacional de prevalencia puntual de pacientes hospitalizados
title Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
spellingShingle Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
title_short Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
title_full Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
title_fullStr Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
title_full_unstemmed Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
title_sort Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
dc.creator.fl_str_mv Restrepo, Marcos I.
Babu, Bettina L.
Reyes, Luis F.
Chalmers, James D.
Soni, Nilam J.
Sibila, Oriol
Faverio, Paola
Cilloniz, Catia
Rodriguez Cintron, William
Aliberti, Stefano
dc.contributor.author.none.fl_str_mv Restrepo, Marcos I.
Babu, Bettina L.
Reyes, Luis F.
Chalmers, James D.
Soni, Nilam J.
Sibila, Oriol
Faverio, Paola
Cilloniz, Catia
Rodriguez Cintron, William
Aliberti, Stefano
description 14 páginas
publishDate 2018
dc.date.issued.none.fl_str_mv 2018-06-06
dc.date.available.none.fl_str_mv 2020-06-02T13:43:29Z
dc.date.accessioned.none.fl_str_mv 6/2/2020 8:43
dc.type.en.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.hasVersion.es_CO.fl_str_mv publishedVersion
dc.identifier.citation.es_CO.fl_str_mv Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 2018; 52: 1701190 [https://doi.org/10.1183/13993003.01190-2017].
dc.identifier.issn.none.fl_str_mv 0903-1936
dc.identifier.other.none.fl_str_mv https://erj.ersjournals.com/content/52/2/1701190.long
https://erj.ersjournals.com/content/erj/52/2/1701190.full.pdf
https://pubmed.ncbi.nlm.nih.gov/29976651/
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/41419
dc.identifier.doi.none.fl_str_mv 10.1183 / 13993003.01190-2017
identifier_str_mv Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J 2018; 52: 1701190 [https://doi.org/10.1183/13993003.01190-2017].
0903-1936
10.1183 / 13993003.01190-2017
url https://erj.ersjournals.com/content/52/2/1701190.long
https://erj.ersjournals.com/content/erj/52/2/1701190.full.pdf
https://pubmed.ncbi.nlm.nih.gov/29976651/
http://hdl.handle.net/10818/41419
dc.language.iso.es_CO.fl_str_mv eng
language eng
dc.relation.ispartofseries.none.fl_str_mv Eur Respir J 2018; 52: 1701190
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.es_CO.fl_str_mv application/pdf
dc.publisher.es_CO.fl_str_mv European Respiratory Journal
dc.source.es_CO.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/41419/2/license_rdf
https://intellectum.unisabana.edu.co/bitstream/10818/41419/3/license.txt
bitstream.checksum.fl_str_mv 4460e5956bc1d1639be9ae6146a50347
f52a2cfd4df262e08e9b300d62c85cab
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952275095027712